{"id":"W2913986976","doi":"10.1093/ecco-jcc/jjy222.035","title":"OP38 Maintenance treatment with mirikizumab, a p19-directed IL-23 antibody: 52-week results in patients with moderately-to-severely active ulcerative colitis","year":2019,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Clinical trial; Internal medicine; Gastroenterology; Placebo; Ulcerative colitis; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007030144,0.0005687965,0.001527919,0.0002702613,0.0002963298,0.0004102683,0.0004621738,0.0005155015,0.004400136],"category_scores_gemma":[0.0006159096,0.0002463502,0.0008065089,0.0002470432,0.0003152779,0.0004992507,0.0002768518,0.001449298,0.0007311789],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000344267,"about_ca_system_score_gemma":0.0005544062,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006143765,"about_ca_topic_score_gemma":0.00106987,"domain_scores_codex":[0.9997677,0.00007622263,0.00002144726,0.0000417341,0.00003272681,0.00006009154],"domain_scores_gemma":[0.999726,0.00004541087,0.00005364068,0.00002757336,0.00001702448,0.0001303843],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.707173,0.01960957,0.00535519,0.000942645,0.0005218647,0.0003663658,0.0001631809,0.0004321291,0.04938597,0.0001133589,0.003753952,0.2121828],"study_design_scores_gemma":[0.3164571,0.5989669,0.07221867,0.0001269015,0.0005890598,0.0004397643,0.0000662,0.0007931911,0.005433792,0.0001827468,0.004679285,0.00004642984],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920684,0.004253217,0.0002582635,0.0002696356,0.00007260493,0.0006661594,0.0006453507,0.00007447344,0.001691911],"genre_scores_gemma":[0.9933495,0.001523308,0.0008062206,0.0003954952,0.0001090101,0.0006978129,0.001056668,0.00001736938,0.002044627],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004400136,"threshold_uncertainty_score":0.0147199,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005619057609049248,"score_gpt":0.2265857623286525,"score_spread":0.2209667047196033,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}